Added to YB: 2026-08-17
Pitch date: 2026-08-13
DEMANT.CO [neutral]
Demant A/S
+0.95%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally.
Market Cap
DKK 62.7B
Pitch Price
DKK 294.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
14.05
P/E
25.91
EV/Sales
3.31
Sector
Health Care Equipment and Supplies
Category
growth
Demant (DEMANT Denmark): Solid
DEMANT.CO (update): Strong Q2, 9% organic growth across all 3 divisions. Hearing Aids +10% (Oticon Zeal launch, volume+pricing), Hearing Care +8% (Kind M&A), Diagnostics +9%. H1 EBIT DKK2.13bn (+15%), 16.5% margin. FY26 guide raised: organic 6-7%, EBIT DKK4.4-4.8bn. Oticon Reveal Q3 rollout catalyst. Kind integration/margin risk. Share recovery already prices in improvement.
Read full article (2 min)